Clinoril and Pregnancy
Complications are possible with Clinoril, and pregnancy presents special problems. While the drug has not been studied extensively in pregnant women, animal studies show side effects on the fetus. Thus, the drug is considered a pregnancy Category C drug. If you are taking Clinoril and pregnancy occurs, your healthcare provider will weigh the benefits to you against the potential risks to the unborn child.
Most healthcare providers do not recommend taking Clinoril® (sulindac) during pregnancy because it can cause problems for the unborn child or complicate labor and delivery. Clinoril should be avoided altogether during the third trimester.
Clinoril is considered a pregnancy Category C medicine by the U.S. Food and Drug Administration (FDA), which means that it has not been studied in pregnant women. However, when studied in pregnant animals, problems were seen with the unborn fetus. This suggests that Clinoril could potentially cause harm to your unborn child. It is important to note, however, that animals do not always respond to medicines the same way that humans do.
The FDA uses a category system to classify the possible risks to a fetus when a specific medicine is taken during pregnancy. Pregnancy Category C is given to medicines that have not been studied in pregnant women but that show side effects to the fetus in animal studies. A pregnancy Category C medicine may still be given to a pregnant woman if the healthcare provider believes that the benefits to the mother outweigh the possible risks to the unborn child.
If you are pregnant or thinking of becoming pregnant while taking Clinoril, let your healthcare provider know. He or she will consider the benefits and risks before making a recommendation for your particular situation.